New hope for rare burning pain: drug trial targets genetic cause

This early-stage study tests whether BHV-7000 can reduce chronic pain in people with inherited erythromelalgia, a rare condition causing severe burning pain due to a genetic mutation. Only 5 adults with a specific NaV1.7 mutation will participate, comparing the drug to a placebo in a crossover design. The main goal is to see if daily pain scores improve.